Mast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammation

British Journal of Pharmacology

Volumn 145, Issue 7, 2005, Pages 845-852

  Wyss, Daniel ^a   Bonneau, Olivier ^a   Trifilieff, Alexandre ^a,b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b Novartis Institutes for Biomedical Research   (United Kingdom)

Author keywords

Adenosine airway hyper reactivity; Asthma; Mast cell; Mice

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); BUDESONIDE; CROMOGLYCATE DISODIUM; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CELL INFILTRATION; DISEASE MODEL; DRUG EFFECT; DRUG INHIBITION; FEMALE; INFLAMMATORY CELL; LUNG LAVAGE; MAST CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SPECIES COMPARISON;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; BUDESONIDE; CROMOLYN SODIUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNIZATION; MAST CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN; PNEUMONIA; RESPIRATORY HYPERSENSITIVITY;

EID: 23744508922     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706271     Document Type: Article

References (47)

1. AALBERS, R., KAUFFMAN, H.F., KOETER, G.H., POSTMA, D.S., DE VRIES, K. & DE MONCHY, J.G. (1991). Dissimilarity in methacholine and adenosine 5′-monophosphate responsiveness 3 and 24h after allergen challenge. Am. Rev. Respir. Dis., 144, 352-357.
2. ALI, S., MUSTAFA, S.J. & METZGER, W.J. (1994a). Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. J. Pharmacol. Exp. Ther., 268, 1328-1334.
3. ALI, S., MUSTAFA, S.J. & METZGER, W.J. (1994b). Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model. Am. J. Physiol., 266, L271-L277.
4. ANDRADE, M.V., HIRAGUN, T. & BEAVEN, M.A. (2004). Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J. Immunol., 172, 7254-7262.
5. ANGUS, R.M. (2002). Inhaled corticosteroids (budesonide): the cornerstone of asthma therapy - what are the options? Pulm. Pharmacol. Ther., 15, 479-484.
6. CHUNN, J.L., YOUNG, H.W.J., BANERJEE, S.K., COLASURDO, G.N. & BLACKBURN, M.R. (2001). Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J. Immunol., 167, 4676-4685.
7. CIESLEWICZ, G., TOMKINSON, A., ADLER, A., DUEZ, C., SCHWARZE, J., TAKEDA, K., LARSON, K.A., LEE, J.J., IRVIN, C.G. & GELFAND, E.W. (1999). The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest., 104, 301-308.
8. COLLIER, J.G. & FULLER, R.W. (1983). Evidence for an effect of sodium cromoglycate on sensory nerves in man. Br. J. Clin. Pharmacol., 16, 639-643.
9. CORTELING, R. & TRIFILIEFF, A. (2004). Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatment. BMC Pharmacol., 4, 4-9.
10. CRIMI, N, PALERMO, F., OLIVERI, R., POLOSA, R., SETTINIERI, I. & MISTRETTA, A. (1992). Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. Eur. Respir. J., 5, 560-565.
11. CUSHLEY, M.J., TATTERSFIELD, A.E. & HOLGATE, S.T. (1983). Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br. J. Clin. Pharmacol., 15, 161-165.
12. DEUSSEN, A. (2000). Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch. Pharmacol., 362, 351-363.
13. EL HASHIM, A., D'AGOSTINO, B., MATERA, M.G. & PAGE, C. (1996). Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br. J. Pharmacol., 119, 1262-1268.
14. FAN, M. & MUSTAFA, S.J. (2002). Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model. Pulm. Pharmacol. Ther., 15, 147-155.
15. FAN, M., QIN, W. & MUSTAFA, S.J. (2003). Characterization of adenosine receptor(s) involved in adenosine-induced bronchoconstriction in an allergic mouse model. Am. J. Physiol., 284, L1012-L1019.
16. FOZARD, J.R. & HANNON, J.P. (2000). Species differences in adenosine receptor-mediated bronchoconstrictor responses. Clin. Exp. Allergy, 30, 1213-1220.
17. FREDHOLM, B.B., IJZERMAN, A.P., JACOBSON, K.A., KLOTZ, K.N. & LINDEN, J. (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 527-552.
18. FUJITANI, Y. & TRIFILIEFF, A. (2003). In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am. J. Respir. Crit. Care Med., 167, 193-198.
19. HANNON, J.P., TIGANI, B., WILLIAMS, I., MAZZONI, L. & FOZARD, J.R. (2001). Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats. Br. J. Pharmacol., 132, 1509-1523.
20. HANNON, J.P., TIGANI, B., WOLBER, C., WILLIAMS, I., MAZZONI, L., HOWES, C. & FOZARD, J.R. (2002). Evidence for an atypical receptor mediating the augmented bronchoconstrictor response to adenosine induced by allergen challenge in actively sensitized Brown Norway rats. Br. J. Pharmacol., 135, 685-696.
21. HASKO, G. & CRONSTEIN, B.N. (2004). Adenosine: an endogenous regulator of innate immunity. Trends Immunol., 25, 33-39.
22. HELD, H.D., MARTIN, C. & UHLIG, S. (1999). Characterization of airway and vascular responses in murine lungs. Br. J. Pharmacol., 126, 1191-1199.
23. HONG, J.L., HO, C.Y., KWONG, K. & LEE, L.Y. (1998). Activation of pulmonary C fibres by adenosine in anaesthetized rats: role of adenosine Al receptors. J. Physiol., 508, 109-118.
24. ISHIZAKA, T., STERK, A.R., DAERON, M., BECKER, E.L. & ISHIZAKA, K. (1985). Biochemical analysis of desensitization of mouse mast cells. J. Immunol., 135, 492-501.
25. JOOS, G.F., O'CONNOR, B., ANDERSON, S.D., CHUNG, F., COCKCROFT, D.W., DAHLEN, B., DIMARIA, G., FORESI, A., HARGREAVE, F.E., HOLGATE, S.T., INMAN, M., LOTVALL, J., MAGNUSSEN, H., POLOSA, R., POSTMA, D.S. & RIEDLER, J. (2003). Indirect airway challenges. Eur. Respir. J., 21, 1050-1068.
26. KETCHELL, R.I., JENSEN, M.W., LUMLEY, P., WRIGHT, A.M., ALLENBY, M.I. & O'CONNOR, B.J. (2002). Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. J. Allergy Clin. Immunol., 110, 603-606.
27. NYCE, J.W. & METZGER, W.J. (1997). DNA antisense therapy for asthma in an animal model. Nature, 385, 721-725.
28. PAUWELS, R.A. & JOOS, G.F. (1995). Characterization of the adenosine receptors in the airways. Arch. Int. Pharmacodyn. Ther., 329, 151-160.
29. PAUWELS, R.A. & VAN DER STRAETEN, M.E. (1987). An animal model for adenosine-induced bronchoconstriction. Am. Rev. Respir. Dis., 136, 374-378.
30. PHILLIPS, G.D., NG, W.H., CHURCH, M.K. & HOLGATE, S.T. (1990). The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5′-monophosphate, and allergen in atopic nonasthmatic subjects. Am. Rev. Respir. Dis., 141, 9-13.
31. PHILLIPS, G.D., SCOTT, V.L., RICHARDS, R. & HOLGATE, S.T. (1989). Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur. Respir. J., 2, 210-217.
32. POLOSA, R., NG, W.H., CRIMI, N., VANCHERI, C., HOLGATE, S.T., CHURCH, M.K. & MISTRETTA, A. (1995). Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am. J. Respir. Crit. Care Med., 151, 624-629.
33. POLOSA, R., PHILLIPS, G.D., RAJAKULASINGAM, K. & HOLGATE, S.T. (1991). The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma. J. Allergy Clin. Immunol., 87, 939-947.
34. POLOSA, R., RORKE, S. & HOLGATE, S.T. (2002). Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax, 57, 649-654.
35. RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
36. RICHARDS, R., PHILLIPS, G.D. & HOLGATE, S.T. (1989). Nedocromil sodium is more potent than sodium cromoglycate against AMP-induced bronchoconstriction in atopic asthmatic subjects. Clin. Exp. Allergy, 19, 285-291.
37. SCHMIDT, D. & RABE, K.F. (2000). Immune mechanisms of smooth muscle hyperreactivity in asthma. J. Allergy Clin. Immunol., 105, 673-682.
38. SHALIT, M. & LEVI-SCHAFFER, F. (1995). Challenge of mast cells with increasing amounts of antigen induces desensitization. Clin. Exp. Allergy, 25, 896-902.
39. SHIN, H.Y., KIM, J.S., AN, N.H., PARK, R.K. & KIM, H.M. (2004). Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Life Sci, 74, 2877-2887.
40. SPICUZZA, L., BONFIGLIO, C. & POLOSA, R. (2003). Research applications and implications of adenosine in diseased airways. Trends Pharmacol. Sci., 24, 409-413.
41. THORNE, J.R. & BROADLEY, K.J. (1994). Adenosine-induced bronchoconstriction in conscious hyperresponsive and sensitized guinea pigs. Am. J. Respir. Crit. Care Med., 149, 392-399.
42. THORNE, J.R., DANAHAY, H. & BROADLEY, K.J. (1996). Analysis of the bronchoconstrictor responses to adenosine receptor agonists in sensitized guinea-pig lungs and trachea. Eur. J. Pharmacol., 316, 263-271.
43. TILLEY, S.L., TSAI, M., WILLIAMS, C.M., WANG, Z.S., ERIKSON, C.J., GALLI, S.J. & KOLLER, B.H. (2003). Identification of A3 receptor- and mast cell-dependent and -independent components of adenosine-mediated airway responsiveness in mice. J. Immunol., 171, 331-337.
44. TRIFILIEFF, A., BENCH. A., HANLEY, M., BAYLEY, D., CAMPBELL, E. & WHITTAKER, P. (2003). PPAR-α and -γ but not -δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-κB-independent effect. Br. J. Pharmacol., 139, 163-171.
45. TRIFILIEFF, A., EL-HASHIM, A. & BERTRAND, C. (2000). Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am. J. Physiol. Lung Cell Mol. Physiol, 279, L1120-L1128.
46. VERLEDEN, G.M., BELVISI, M.G., STRETTON, C.D. & BARNES, P.J. (1991). Nedocromil sodium modulates nonadrenergic, noncholinergic bronchoconstrictor nerves in guinea pig airways in vitro. Am. Rev. Respir. Dis., 143, 114-118.
47. WERSHIL, B.K., FURUTA, G.T., LAVIGNE, J.A., CHOUDHURY, A.R., WANG, Z.S. & GALLI, S.J. (1995). Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol., 154, 1391-1398.